Rubicon Genomics is Biotechnology in United States that focus on quality companion products business. Founded in 2000. They cover business area such as Provider, high quality companion product, pre-analytical amplification, nucleic acid, research and commercial application, WGA, Whole Transcriptome Amplification, ThruPLEX, -FD, ease, use, robustness, speed, result, physician, less sample, a diverse set, sample source.
2000
( 24 years old in 2024 )
Quality Companion Products
-
4743 Venture Drive
Ann Arbor, MI 48108
United States
Private
Providerhigh quality companion productpre-analytical amplificationnucleic acidresearch and commercial applicationWGAWhole Transcriptome AmplificationThruPLEX-FDeaseuserobustnessspeedresultphysicianless samplea diverse setsample source
* We use standard office opening hours in near Rubicon Genomics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Rubicon Genomics is Biotechnology business from United States that founded in 2000 (24 years old in 2024), Rubicon Genomics business is focusing on Quality Companion Products.
Rubicon Genomics headquarter office and corporate office address is located in 4743 Venture Drive Ann Arbor, MI 48108 United States.
Rubicon Genomics was founded in United States.
In 2024, Rubicon Genomics is currently focus on quality companion products sector.
Above is snippet of Google Trends for "quality companion products" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Rubicon Genomics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
